Suppr超能文献

评估Cobas-Bact系统对阳性尿液标本中肠杆菌科细菌的直接快速鉴定及抗菌药物敏感性检测。

Evaluation of the Cobas-Bact system for direct and rapid identification and antimicrobial susceptibility testing of Enterobacteriaceae from positive urine specimens.

作者信息

Kamm W, Wenger A, Bille J

机构信息

Clinical Bacteriology Laboratory, IMUL, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

出版信息

Zentralbl Bakteriol. 1989 Sep;271(3):272-80. doi: 10.1016/s0934-8840(89)80025-8.

Abstract

A direct antimicrobial susceptibility test and a direct identification of Gram-stained urine specimens positive for Enterobacteriaceae using a new instrument (Cobas-Bact) were compared by means of the conventional Kirby-Bauer agar diffusion disk method and the spot indole test, an in-house set of identification tests or API 20E. Bacteria from 191 cases of monomicrobial bacteriuria due to members of the family Enterobacteriaceae were tested. Direct susceptibility testing was performed in 180 cases (94%), providing 1649 antibiotic-microorganism combinations. A complete agreement was reached in 82% and essential agreement in 92% of cases. Minor discrepancies were found in 163 (9.9%) major ones in 125 (7.6%) and very major ones in 10 (0.6%) of examinations. 72% of all minor and 71% of all major discrepancies were caused by two antibiotics: cephalothin and nitrofurantoin. Of the very major discrepancies, 50% were due to amoxicillin. Of 171 direct identifications obtained, 130 (76%) were "high-confidence" correct identifications (percentage of likelihood p greater than or equal to 80%), 25 (14.6%) "low-confidence" identifications (percentage of likelihood p less than 80%) and 16 (9.4%) misidentifications. On the whole, this direct and rapid Cobas-Bact identification and susceptibility testing procedure provided satisfying information within 5-6 h after collection of urine specimens positive for members of the Enterobacteriaceae family.

摘要

采用传统的 Kirby-Bauer 琼脂扩散纸片法和吲哚试验、内部鉴定试验组合或 API 20E,对使用新型仪器(Cobas-Bact)对革兰氏染色尿标本中肠杆菌科阳性菌进行直接药敏试验和直接鉴定的结果进行比较。对 191 例由肠杆菌科成员引起的单菌尿症患者的细菌进行了检测。180 例(94%)进行了直接药敏试验,共提供了 1649 种抗生素-微生物组合。82%的病例达成完全一致,92%的病例达成基本一致。在 163 次(9.9%)检测中发现轻微差异,125 次(7.6%)检测中发现主要差异,10 次(0.6%)检测中发现非常主要的差异。所有轻微差异的 72%和所有主要差异的 71%是由两种抗生素引起的:头孢噻吩和呋喃妥因。在非常主要的差异中,50%是由阿莫西林引起的。在获得的 171 次直接鉴定中,130 次(76%)为“高置信度”正确鉴定(可能性百分比 p 大于或等于 80%),25 次(14.6%)为“低置信度”鉴定(可能性百分比 p 小于 80%),16 次(9.4%)为错误鉴定。总体而言,这种直接快速的 Cobas-Bact 鉴定和药敏试验程序在收集到肠杆菌科阳性尿标本后 5 - 6 小时内提供了令人满意的信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验